• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
FoxO transcription factors are required for hepatic HDL cholesterol clearance.FoxO 转录因子对于肝脏清除 HDL 胆固醇是必需的。
J Clin Invest. 2018 Apr 2;128(4):1615-1626. doi: 10.1172/JCI94230. Epub 2018 Mar 19.
2
Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.内皮型脂肪酶在肝中的过表达降低了高密度脂蛋白,但维持了小鼠的胆固醇逆向转运:清道夫受体 B 类 I/ATP 结合盒转运体 A1 依赖性途径的作用。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1454-1467. doi: 10.1161/ATVBAHA.118.311056. Epub 2018 May 10.
3
MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I.MicroRNA-24 通过抑制清道夫受体 B 类 I 的转录后抑制从高密度脂蛋白胆固醇中选择性摄取脂质,从而加剧动脉粥样硬化。
Atherosclerosis. 2018 Mar;270:57-67. doi: 10.1016/j.atherosclerosis.2018.01.045. Epub 2018 Feb 4.
4
Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.残余高密度脂蛋白颗粒的细胞摄取增强:胰岛素抵抗和高甘油三酯血症中高密度脂蛋白降低的一种机制。
Circ Res. 2008 Jul 18;103(2):159-66. doi: 10.1161/CIRCRESAHA.108.178756. Epub 2008 Jun 12.
5
Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice.I型B类清道夫受体介导小鼠肝脏对高密度脂蛋白相关胆固醇酯的选择性摄取。
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):143-8. doi: 10.1161/01.ATV.0000149381.16166.c6. Epub 2004 Nov 4.
6
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol.靶向突变揭示了SR-BI在肝脏选择性摄取高密度脂蛋白胆固醇中的核心作用。
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4619-24. doi: 10.1073/pnas.95.8.4619.
7
Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.CLA-1与人类PDZK1在小鼠肝脏中的共表达调节高密度脂蛋白胆固醇代谢。
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1298-303. doi: 10.1161/ATVBAHA.108.165845. Epub 2008 Apr 10.
8
In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis.脂肪组织中SR-BI在肥胖和胆固醇稳态的营养及激素调节中作用的体内证据。
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1340-5. doi: 10.1161/ATVBAHA.106.136382. Epub 2007 Mar 15.
9
Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.在清道夫受体 B 类 I 型(SR-BI)敲除小鼠中通过胆固醇酯转移蛋白表达恢复高密度脂蛋白水平不能使与 SR-BI 缺乏相关的病理正常化。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1439-45. doi: 10.1161/ATVBAHA.110.205153. Epub 2010 Apr 29.
10
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.胰岛素抵抗和2型糖尿病中高密度脂蛋白代谢及胆固醇逆向转运的改变:脂解酶、卵磷脂胆固醇酰基转移酶和脂质转运蛋白的作用
Eur J Clin Invest. 2003 Dec;33(12):1051-69. doi: 10.1111/j.1365-2362.2003.01263.x.

引用本文的文献

1
Dysfunction of Autophagy in Adipose Tissue Macrophages Regulated via FoxO1 in Obesity-Related Severe Acute Pancreatitis.肥胖相关性重症急性胰腺炎中通过FoxO1调控的脂肪组织巨噬细胞自噬功能障碍
Int J Mol Sci. 2025 Jul 25;26(15):7206. doi: 10.3390/ijms26157206.
2
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling.ABCA9,内质网胆固醇转运蛋白,通过 SREBP-2 信号抑制乳腺癌细胞增殖。
Cancer Sci. 2023 Apr;114(4):1451-1463. doi: 10.1111/cas.15710. Epub 2023 Jan 18.
3
The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus.叉头框蛋白 O 在糖尿病发病机制和治疗中的作用。
Int J Mol Sci. 2022 Oct 1;23(19):11611. doi: 10.3390/ijms231911611.
4
Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway.肝脏 FoxOs 通过载脂蛋白 M/鞘氨醇 1-磷酸途径将胰岛素信号与血浆脂蛋白代谢联系起来。
J Clin Invest. 2022 Apr 1;132(7). doi: 10.1172/JCI146219.
5
An integrative transcriptional logic model of hepatic insulin resistance.肝脏胰岛素抵抗的综合转录逻辑模型。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2102222118.
6
Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Atherosclerosis.载脂蛋白 AI 介导的清道夫受体 BI 可能与动脉粥样硬化有关。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211029710. doi: 10.1177/10760296211029710.
7
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.载脂蛋白 C3 升高可增加 1 型糖尿病患者的心血管风险。
J Clin Invest. 2019 Jul 11;129(10):4165-4179. doi: 10.1172/JCI127308.
8
Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.肝叉头框蛋白 A3 调节载脂蛋白 A-I(载脂蛋白 A-I)表达、胆固醇外排和动脉粥样硬化形成。
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1574-1587. doi: 10.1161/ATVBAHA.119.312610. Epub 2019 Jul 11.
9
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.肝脏 WASH 复合物对于有效清除血浆 LDL 和 HDL 胆固醇是必需的。
JCI Insight. 2019 Jun 6;4(11). doi: 10.1172/jci.insight.126462.
10
Recent advances in understanding and managing cholesterol gallstones.胆固醇性胆结石诊治的最新进展
F1000Res. 2018 Sep 24;7. doi: 10.12688/f1000research.15505.1. eCollection 2018.

本文引用的文献

1
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.清道夫受体BI中的罕见变异会升高高密度脂蛋白胆固醇并增加冠心病风险。
Science. 2016 Mar 11;351(6278):1166-71. doi: 10.1126/science.aad3517.
2
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.FoxO1整合了胰岛素对肝脏葡萄糖生成和葡萄糖利用的直接和间接作用。
Nat Commun. 2015 May 12;6:7079. doi: 10.1038/ncomms8079.
3
A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.一种编码缺乏DNA结合能力的FoxO1的突变等位基因对肝脏葡萄糖和脂质代谢有不同的调节作用。
Diabetes. 2015 Jun;64(6):1951-65. doi: 10.2337/db14-1506. Epub 2015 Jan 9.
4
Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.肝脏脂肪生成与葡萄糖生成的综合调控需要FoxO转录因子。
Nat Commun. 2014 Oct 13;5:5190. doi: 10.1038/ncomms6190.
5
High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice.低密度脂蛋白受体缺陷小鼠的高密度脂蛋白代谢
J Lipid Res. 2014 Sep;55(9):1914-24. doi: 10.1194/jlr.M048819. Epub 2014 Jun 22.
6
Challenges in using cultured primary rodent hepatocytes or cell lines to study hepatic HDL receptor SR-BI regulation by its cytoplasmic adaptor PDZK1.使用培养的原代啮齿动物肝细胞或细胞系研究其细胞质衔接蛋白 PDZK1 对肝 HDL 受体 SR-BI 调节的挑战。
PLoS One. 2013 Jul 23;8(7):e69725. doi: 10.1371/journal.pone.0069725. Print 2013.
7
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?并非那么简单的高密度脂蛋白故事:是时候修正高密度脂蛋白胆固醇假说了吗?
Nat Med. 2012 Sep;18(9):1344-6. doi: 10.1038/nm.2937.
8
Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice.mTORC1 和 PCSK9 对小鼠肝脏 LDL 受体的调控。
J Clin Invest. 2012 Apr;122(4):1262-70. doi: 10.1172/JCI61919. Epub 2012 Mar 19.
9
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.胰岛素在体内调节肝脏代谢,而不依赖于肝 Akt 和 Foxo1。
Nat Med. 2012 Feb 19;18(3):388-95. doi: 10.1038/nm.2686.
10
Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia.12-羟化胆汁酸生成受损将肝胰岛素信号与血脂异常联系起来。
Cell Metab. 2012 Jan 4;15(1):65-74. doi: 10.1016/j.cmet.2011.11.010. Epub 2011 Dec 22.

FoxO 转录因子对于肝脏清除 HDL 胆固醇是必需的。

FoxO transcription factors are required for hepatic HDL cholesterol clearance.

机构信息

Naomi Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, New York, USA.

Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

出版信息

J Clin Invest. 2018 Apr 2;128(4):1615-1626. doi: 10.1172/JCI94230. Epub 2018 Mar 19.

DOI:10.1172/JCI94230
PMID:29408809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5873864/
Abstract

Insulin resistance and type 2 diabetes are associated with low levels of high-density lipoprotein cholesterol (HDL-C). The insulin-repressible FoxO transcription factors are potential mediators of the effect of insulin on HDL-C. FoxOs mediate a substantial portion of insulin-regulated transcription, and poor FoxO repression is thought to contribute to the excessive glucose production in diabetes. In this work, we show that mice with liver-specific triple FoxO knockout (L-FoxO1,3,4), which are known to have reduced hepatic glucose production, also have increased HDL-C. This was associated with decreased expression of the HDL-C clearance factors scavenger receptor class B type I (SR-BI) and hepatic lipase and defective selective uptake of HDL cholesteryl ester by the liver. The phenotype could be rescued by re-expression of SR-BI. These findings demonstrate that hepatic FoxOs are required for cholesterol homeostasis and HDL-mediated reverse cholesterol transport to the liver.

摘要

胰岛素抵抗和 2 型糖尿病与高密度脂蛋白胆固醇 (HDL-C) 水平降低有关。胰岛素抑制型 FoxO 转录因子是胰岛素对 HDL-C 作用的潜在介质。FoxOs 介导了胰岛素调节转录的大部分,而 FoxO 抑制不良被认为导致了糖尿病中葡萄糖产生的过度。在这项工作中,我们表明,肝脏特异性三重 FoxO 敲除 (L-FoxO1,3,4) 的小鼠,已知其肝葡萄糖生成减少,也具有增加的 HDL-C。这与 HDL-C 清除因子清道夫受体 B 类 I (SR-BI) 和肝脂肪酶的表达降低以及肝脏对 HDL 胆固醇酯的选择性摄取缺陷有关。该表型可以通过重新表达 SR-BI 来挽救。这些发现表明,肝 FoxOs 是胆固醇稳态和 HDL 介导的胆固醇逆转运到肝脏所必需的。